24/7 Market News Snapshot 13 January, 2025 – Neuronetics, Inc. Common Stock (NASDAQ:STIM)

January 13, 2025

DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:STIM) are discussed in this article.
Neuronetics, Inc. has demonstrated significant momentum in the markets, achieving a notable increase in its stock price, which opened at $1.95 and surged to a peak of $2.216—a remarkable gain of 29.59% from the previous day’s close of $1.710. The trading session saw a robust volume of 1.32 million shares, indicating keen investor interest in the company’s non-invasive treatment innovations for mental health.

In parallel with its impressive market performance, Neuronetics recently disclosed preliminary financial results for the fourth quarter and full year ending December 31, 2024. The company reported unaudited revenues of $22.1 million for the fourth quarter, with a full-year revenue of $74.5 million, reflecting a strong standalone performance and successful integration of Greenbrook TMS, which was acquired on December 9, 2024. This strategic merger is expected to propel Neuronetics into a leading position in mental health treatment by combining its NeuroStar technology with Greenbrook’s extensive clinic network. As a result, the company anticipates annualized cost synergies of over $22 million and a revenue growth forecast of 12% to 19% for 2025.

Keith J. Sullivan, President and CEO of Neuronetics, expressed optimism regarding the integration’s potential to enhance services and expedite the path to profitability. The company projects total revenues for 2025 between $145 million and $155 million, alongside a gross margin target of approximately 55%. Neuronetics also expects to achieve cash flow breakeven by the third quarter.

In addition to its financial strategies, Neuronetics has launched its Better Me Provider program and secured FDA clearance for NeuroStar Advanced Therapy as a first-line treatment for adolescents facing major depressive disorder, underscoring its commitment to advancing mental health solutions. As the company moves forward, stakeholders can expect continued innovation and growth in the mental health sector.

Related news for (STIM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.